Aeglea Bio Therapeutics Inc (NASDAQ:AGLE)

0.511
Delayed Data
As of Jul 01
 +0.0059 / +1.17%
Today’s Change
0.50
Today|||52-Week Range
8.50
-89.24%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Shanafelt Armen B
Director
Buy12/09/2021121,799$3.67$447.0K-85.91%
Quinn Anthony G
President & Chief Executive Officer
Buy3/16/202280,079$2.34$187.4K-78.83%
Alspaugh Jonathan D
Chief Financial Officer
Buy12/09/202150,000$3.72$186.0K-85.91%
Quinn Anthony G
President & Chief Executive Officer
Buy12/09/202143,108$3.70$159.5K-85.91%
Alspaugh Jonathan D
Chief Financial Officer
Buy3/11/202275,000$2.08$156.0K-74.37%
Alspaugh Jonathan D
Chief Financial Officer
Buy8/17/202123,392$6.50$152.0K-92.18%
Quinn Anthony G
President & Chief Executive Officer
Buy3/14/202267,472$1.93$130.2K-73.01%
Quinn Anthony G
President & Chief Executive Officer
Buy3/15/202242,417$1.86$78.9K-72.72%
Quinn Anthony G
President & Chief Executive Officer
Buy3/11/202234,777$2.06$71.6K-74.37%
Alspaugh Jonathan D
Chief Financial Officer
Buy8/16/20219,780$6.37$62.3K-92.08%
Page of 3